Alex G. Howarth - 17 May 2021 Form 4 Insider Report for MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Role
Chief Financial Officer
Signature
/s/ Brian J. Lynch, As attorney-in-fact for Reporting Person
Issuer symbol
MDGL
Transactions as of
17 May 2021
Net transactions value
$0
Form type
4
Filing time
19 May 2021, 15:40:28 UTC
Next filing
03 Nov 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MDGL Stock Option (Right to Buy) Award $0 +65,000 $0.000000 65,000 17 May 2021 Common Stock 65,000 $134.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 25% of the shares on the first anniversary of the date of grant (05/17/2022) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three month period, provided the Reporting Person continues in service with the Issuer on each such date.